Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.7.6 (
RNA polymerase
)
34,946
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Expression systems based on the selective transcription of genes cloned behind a T7 promoter, by T7
RNA polymerase
, display a non-negligible basal expression when the T7
RNA polymerase
gene is present within the host organism before induction of the system. This is a problem, especially for cloning and controlled expression of genes toxic to the host organism. We have circumvented this problem by taking advantage of abortive T7 infection of E. coli (P1), in the course of which T7
RNA polymerase
is synthesized but bacterial growth is not quantitatively impaired. We have tested this system with three reporter genes, the
6-phospho-beta-galactosidase
gene of Staphylococcus aureus, the luciferase operon of Vibrio harveyi, and the rabbit beta-globin gene; we have found very low basal levels, while, upon T7 infection, transcription is at least as efficient as in other in vivo T7
RNA polymerase
systems in use.
...
PMID:T7 infection-dependent selective expression of cloned genes in P1-lysogenic Escherichia coli. 193 Jan 65